Bio Key International (BKYI) Equity Average (2016 - 2025)
Bio Key International (BKYI) has disclosed Equity Average for 15 consecutive years, with $6.4 million as the latest value for Q3 2025.
- Quarterly Equity Average rose 1496.94% to $6.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Sep 2025, up 1496.94% year-over-year, with the annual reading at $2.4 million for FY2024, 24.03% down from the prior year.
- Equity Average hit $6.4 million in Q3 2025 for Bio Key International, down from $7.2 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $20.0 million in Q1 2021 to a low of -$461625.0 in Q3 2024.
- Historically, Equity Average has averaged $8.1 million across 5 years, with a median of $6.4 million in 2025.
- Biggest five-year swings in Equity Average: skyrocketed 6164.77% in 2021 and later crashed 221.55% in 2024.
- Year by year, Equity Average stood at $16.6 million in 2021, then tumbled by 50.22% to $8.3 million in 2022, then tumbled by 96.5% to $289008.0 in 2023, then surged by 575.6% to $2.0 million in 2024, then skyrocketed by 230.27% to $6.4 million in 2025.
- Business Quant data shows Equity Average for BKYI at $6.4 million in Q3 2025, $7.2 million in Q2 2025, and $5.6 million in Q1 2025.